A novel mutation in ferroportin implicated in iron overload

Journal of Hepatology

Volumn 46, Issue 5, 2007, Pages 921-926

  Wallace, Daniel F ^a   Dixon, Jeannette L ^a   Ramm, Grant A ^a   Anderson, Gregory J ^a   Powell, Lawrie W ^a   Subramaniam, V Nathan ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Autosomal dominant; Ferroportin; Iron overload; Mutation detection; Real time PCR

Indexed keywords

FERRITIN; FERROPORTIN; HEPCIDIN; IRON; IRON BINDING PROTEIN; TRANSFERRIN; UNCLASSIFIED DRUG;

AGED; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CELL LEVEL; DENATURATION; DNA SEQUENCE; FERROPORTIN GENE; GENE; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IRON METABOLISM; IRON OVERLOAD; IRON TRANSPORT; MALE; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHLEBOTOMY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SEQUENCE ANALYSIS;

AGED; AMINO ACID SUBSTITUTION; BIOPSY, NEEDLE; CATION TRANSPORT PROTEINS; CELLS, CULTURED; FERRITINS; HUMANS; IRON OVERLOAD; IRON-REGULATORY PROTEINS; LIVER; MALE; MUTATION; NEW ZEALAND;

EID: 34047175337     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.01.033     Document Type: Article

References (20)

1. O'Neil J., and Powell L. Clinical aspects of hemochromatosis. Semin Liver Dis 25 (2005) 381-391
2. Feder J.N., Gnirke A., Thomas W., Tsuchihashi Z., Ruddy D.A., Basava A., et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13 (1996) 399-408
3. Papanikolaou G., Samuels M.E., Ludwig E.H., MacDonald M.L., Franchini P.L., Dube M.P., et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 36 (2004) 77-82
4. Roetto A., Papanikolaou G., Politou M., Alberti F., Girelli D., Christakis J., et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 33 (2003) 21-22
5. Camaschella C., Roetto A., Cali A., De Gobbi M., Garozzo G., Carella M., et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 25 (2000) 14-15
6. Njajou O.T., Vaessen N., Joosse M., Berghuis B., van Dongen J.W., Breuning M.H., et al. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 28 (2001) 213-214
7. Montosi G., Donovan A., Totaro A., Garuti C., Pignatti E., Cassanelli S., et al. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 108 (2001) 619-623
8. Pietrangelo A. The ferroportin disease. Blood Cells Mol Dis 32 (2004) 131-138
9. Wallace D.F., Clark R.M., Harley H.A., and Subramaniam V.N. Autosomal dominant iron overload due to a novel mutation of ferroportin1 associated with parenchymal iron loading and cirrhosis. J Hepatol 40 (2004) 710-713
10. Nemeth E. Ferroportin mutations: a tale of two phenotypes. Blood 105 (2005) 3763-3764
11. de Domenico I., Ward D.M., Musci G., and Kaplan J. Iron overload due to mutations in ferroportin. Haematologica 91 (2006) 92-95
12. Schimanski L.M., Drakesmith H., Merryweather-Clarke A.T., Viprakasit V., Edwards J.P., Sweetland E., et al. In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations. Blood 105 (2005) 4096-4102
13. Drakesmith H., Schimanski L.M., Ormerod E., Merryweather-Clarke A.T., Viprakasit V., Edwards J.P., et al. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood 106 (2005) 1092-1097
14. de Domenico I., Ward D.M., Nemeth E., Vaughn M.B., Musci G., Ganz T., et al. The molecular basis of ferroportin-linked hemochromatosis. Proc Natl Acad Sci USA 102 (2005) 8955-8960
15. Liu X.B., Yang F., and Haile D.J. Functional consequences of ferroportin 1 mutations. Blood Cells Mol Dis 35 (2005) 33-46
16. Wallace D.F., Pedersen P., Dixon J.L., Stephenson P., Searle J.W., Powell L.W., et al. Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis. Blood 100 (2002) 692-694
17. Hobbs S., Jitrapakdee S., and Wallace J.C. Development of a bicistronic vector driven by the human polypeptide chain elongation factor 1alpha promoter for creation of stable mammalian cell lines that express very high levels of recombinant proteins. Biochem Biophys Res Commun 252 (1998) 368-372
18. Scott S.P., Teh A., Peng C., and Lavin M.F. One-step site-directed mutagenesis of ATM cDNA in large (20 kb) plasmid constructs. Hum Mutat 20 (2002) 323
19. Wallace D.F., Jones M.D., Pedersen P., Rivas L., Sly L.I., and Subramaniam V.N. Purification and partial characterisation of recombinant human hepcidin. Biochimie 88 (2006) 31-37
20. McGregor J.A., Shayeghi M., Vulpe C.D., Anderson G.J., Pietrangelo A., Simpson R.J., et al. Impaired iron transport activity of ferroportin 1 in hereditary iron overload. J Membr Biol 206 (2005) 3-7